Silence Therapeutics plc Increase Decrease Through Share-based Payment Transactions
Silence Therapeutics plc (SLNCF) reported Increase Decrease Through Share-based Payment Transactions of GBP 13.05 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2024-03-13
| Period end | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|
| 2023-12-31 | 13.05M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 10.25M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 8.63M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | 4.39M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | 584.00K GBP 20-F · filed 2022-03-17 |
| 2018-12-31 | 681.00K GBP 20-F/A · filed 2021-04-29 |